Ryan Maynard - Feb 8, 2024 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Feb 8, 2024
Transactions value $
-$2,909
Form type
4
Date filed
2/12/2024, 05:15 PM
Previous filing
Feb 5, 2024
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$2.91K -5.49K -40.65% $0.53 8.01K Feb 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on September 14, 2023 accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.